Y Oda

939 total citations
21 papers, 778 citations indexed

About

Y Oda is a scholar working on Immunology, Neurology and Molecular Biology. According to data from OpenAlex, Y Oda has authored 21 papers receiving a total of 778 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Immunology, 6 papers in Neurology and 5 papers in Molecular Biology. Recurrent topics in Y Oda's work include Immune Cell Function and Interaction (5 papers), Immunotherapy and Immune Responses (4 papers) and Immune Response and Inflammation (3 papers). Y Oda is often cited by papers focused on Immune Cell Function and Interaction (5 papers), Immunotherapy and Immune Responses (4 papers) and Immune Response and Inflammation (3 papers). Y Oda collaborates with scholars based in Japan and United States. Y Oda's co-authors include H Kikuchi, Jutaro Takahashi, Masakazu Hatanaka, Michael Jaye, Hajime Mori, Koji Igarashi, Manabu Fukumoto, Tomokazu Aoki, Shin‐Ichi Miyatake and Tasuku Honjo and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Experimental Medicine and British Journal of Cancer.

In The Last Decade

Y Oda

20 papers receiving 749 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Y Oda Japan 13 357 212 174 154 124 21 778
S H Bigner United States 11 342 1.0× 167 0.8× 280 1.6× 79 0.5× 141 1.1× 20 749
Hirofumi Naganuma Japan 22 421 1.2× 287 1.4× 237 1.4× 236 1.5× 255 2.1× 55 1.2k
Alessandra Dorcaratto Italy 17 517 1.4× 390 1.8× 134 0.8× 247 1.6× 149 1.2× 24 1.2k
Demetrios C. Nikas United States 9 290 0.8× 138 0.7× 154 0.9× 75 0.5× 86 0.7× 16 817
D Jadayel United Kingdom 14 420 1.2× 375 1.8× 334 1.9× 139 0.9× 131 1.1× 21 1.1k
Shobha Castelino‐Prabhu United States 10 486 1.4× 232 1.1× 153 0.9× 86 0.6× 41 0.3× 15 796
Tanya A. Rege United States 8 339 0.9× 153 0.7× 111 0.6× 80 0.5× 44 0.4× 13 735
Noriaki Sugawa Japan 8 544 1.5× 470 2.2× 331 1.9× 96 0.6× 151 1.2× 13 1.1k
Kou Nakagawa Japan 13 259 0.7× 152 0.7× 121 0.7× 32 0.2× 111 0.9× 27 605
Rita Bussolari Italy 10 322 0.9× 233 1.1× 388 2.2× 138 0.9× 46 0.4× 13 784

Countries citing papers authored by Y Oda

Since Specialization
Citations

This map shows the geographic impact of Y Oda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Y Oda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Y Oda more than expected).

Fields of papers citing papers by Y Oda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Y Oda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Y Oda. The network helps show where Y Oda may publish in the future.

Co-authorship network of co-authors of Y Oda

This figure shows the co-authorship network connecting the top 25 collaborators of Y Oda. A scholar is included among the top collaborators of Y Oda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Y Oda. Y Oda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Takagaki, Masao, Koji Ono, Y Oda, et al.. (1996). Hydroxylforms of p-boronophenylalanine as potential boron carriers on boron neutron capture therapy for malignant brain tumors.. PubMed. 56(9). 2017–20. 12 indexed citations
2.
Yin, Dali, et al.. (1994). Tumour necrosis factor-α induces an increase in susceptibility of human glioblastoma U87-MG cells to natural killer cell-mediated lysis. British Journal of Cancer. 69(4). 627–632. 14 indexed citations
3.
Kondo, Seiji, Dali Yin, Junichiro Takeuchi, et al.. (1994). bcl-2 gene enables rescue from in vitro myelosuppression (bone marrow cell death) induced by chemotherapy. British Journal of Cancer. 70(3). 421–426. 19 indexed citations
4.
Ueba, Tetsuya, Tetsuya Nosaka, Jutaro Takahashi, et al.. (1994). Transcriptional regulation of basic fibroblast growth factor gene by p53 in human glioblastoma and hepatocellular carcinoma cells.. Proceedings of the National Academy of Sciences. 91(19). 9009–9013. 120 indexed citations
5.
Yoshida, Junji, Koshiro Sugita, Tatsuya Kobayashi, et al.. (1993). Prognosis of intracranial germ cell tumours: Effectiveness of chemotherapy with cisplatin and etoposide (CDDP and VP-16). Acta Neurochirurgica. 120(3-4). 111–117. 101 indexed citations
6.
Ohtsu, A., Shigeyuki Yoshida, Takahiro Fujii, et al.. (1993). Small Cell Carcinoma of the Esophagus with an Esophago-mediastinal Fistula Successfully Treated by Chemoradiation Therapy and Intubation: A Case Report. Japanese Journal of Clinical Oncology. 23(6). 373–7. 10 indexed citations
7.
Kondo, Seiji, Shin‐Ichi Miyatake, K Iwasaki, et al.. (1992). Human Glioma-Specific Antigens Detected by Monoclonal Antibodies. Neurosurgery. 30(4). 506–511. 8 indexed citations
8.
Yamasaki, Toshiki, et al.. (1992). Primary intracerebral malignant lymphoma associated with different histological types of carcinoma: Report of two cases. Surgical Neurology. 37(6). 464–471. 1 indexed citations
9.
Aoki, Tomokazu, et al.. (1992). SYNERGY OF INTERLEUKIN-5 WITH INTERLEUKIN-2 IN THE GENERATION OF LYMPHOKINE-ACTIVATED KILLER-CELLS. International Journal of Oncology. 1(2). 165–74. 1 indexed citations
10.
Aoki, Tomokazu, Kei Tashiro, Shin‐Ichi Miyatake, et al.. (1992). Expression of murine interleukin 7 in a murine glioma cell line results in reduced tumorigenicity in vivo.. Proceedings of the National Academy of Sciences. 89(9). 3850–3854. 116 indexed citations
11.
Iwasaki, K, et al.. (1990). Infiltrative and cytolytic activities of lymphokine-activated killer cells against a human glioma spheroid model.. PubMed. 50(8). 2429–36. 21 indexed citations
12.
Takahashi, Jutaro, Hajime Mori, Manabu Fukumoto, et al.. (1990). Gene expression of fibroblast growth factors in human gliomas and meningiomas: demonstration of cellular source of basic fibroblast growth factor mRNA and peptide in tumor tissues.. Proceedings of the National Academy of Sciences. 87(15). 5710–5714. 240 indexed citations
13.
Miyatake, Shin‐Ichi, H Kikuchi, Y Oda, et al.. (1990). Decreased susceptibility of lined human gliosarcoma cells to lymphokine-activated killer cell cytolysis by gamma-interferon treatment.. PubMed. 50(3). 596–600. 17 indexed citations
14.
Aoki, Tomokazu, H Kikuchi, Shin‐Ichi Miyatake, et al.. (1989). Interleukin 5 enhances interleukin 2-mediated lymphokine-activated killer activity.. The Journal of Experimental Medicine. 170(2). 583–588. 26 indexed citations
15.
Matsumoto, Miho, Tetsu Akiyama, Shin‐Ichi Miyatake, et al.. (1989). Expression of proto-oncogene products during drug-induced differentiation of a neuroblastoma cell line SK-N-DZ. Acta Neuropathologica. 79(2). 217–221. 12 indexed citations
16.
Murata, Teruasa, et al.. (1983). [Arteriovenous malformations of the choroid plexus--a case report].. PubMed. 11(8). 867–73. 5 indexed citations
17.
Oda, Y, Yasuo Uchida, Tsukasa Murata, et al.. (1982). [Treatment of brain tumors with anticancer pellet--experimental and clinical study (author's transl)].. PubMed. 10(4). 375–81. 18 indexed citations
18.
Oda, Y, et al.. (1982). [Clinical evaluation of artificial blood substitute (fluosol-DA 20%) in patients of cerebral ischemia].. PubMed. 10(6). 637–44. 7 indexed citations
19.
Yonekawa, Yasuhiro, Waro Taki, Hajime Handa, Hiromu Miyake, & Y Oda. (1980). Experiences of Lasermicrosurgery for removal of brain tumor. Nippon Laser Igakkaishi. 1(1). 269–278. 4 indexed citations
20.
Araya, Ignacio, et al.. (1966). [Surgical experiences with congenital coronary arteriovenous fistula].. PubMed. 19(4). 281–4. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026